SEC Gives Green Light for Pharmacopeia Spin-off | GenomeWeb

NEW YORK, April 20 (GenomeWeb News) - The SEC has declared the registration statement on Form 10 of Pharmacopeia Drug Discovery effective, thus clearing the way for PDD's spin-off to Pharmacopeia stockholders, Pharmacopeia said yesterday.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.